These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7200715)

  • 1. [Plasma testosterone and sex hormone transport globulin in patients with prostatic carcinoma under treatment].
    Daponte DP; Pidcock M; Robinson MR; Smith PH
    Actas Urol Esp; 1982; 6(1):17-20. PubMed ID: 7200715
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of diethylstilbestrol and estramustine phosphate on serum sex hormone binding globulin and testosterone levels in prostate cancer patients.
    Karr JP; Wajsman Z; Kirdani RY; Murphy GP; Sandberg AA
    J Urol; 1980 Aug; 124(2):232-6. PubMed ID: 7190620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of estramustine phosphate on free androgens. A comparative study of the effect of orchiectomy and estramustine phosphate on free androgens in patients with prostatic cancer.
    Van Poppel H; Werbrouck PW; Baert L
    Acta Urol Belg; 1990; 58(4):89-95. PubMed ID: 2093302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inhibition of the free, biologically active testosterone level by Turisteron in patients with prostate cancer].
    Stahl F; Schnorr D; Rohde W; Dörner G
    Z Urol Nephrol; 1987 Mar; 80(3):135-8. PubMed ID: 3604472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex hormone binding globulin in carcinoma of the prostate.
    Houghton AL; Turner R; Cooper EH
    Br J Urol; 1977 Jun; 49(3):227-32. PubMed ID: 562212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma hormone levels in patients with prostatic carcinoma treated with diethylstilboestrol and estramustine.
    Bishop MC; Selby C; Taylor M
    Br J Urol; 1985 Oct; 57(5):542-7. PubMed ID: 3904908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Long-term study of plasma testosterone levels in hormone therapy of prostatic cancer].
    Hájek J; Hanselová M; Vrubel F
    Vnitr Lek; 1981 Sep; 27(9):852-60. PubMed ID: 7293030
    [No Abstract]   [Full Text] [Related]  

  • 8. Absence of relationship between steroid hormone levels and prostate cancer tumor grade.
    Sher DJ; Mantzoros C; Jacobus S; Regan MM; Lee GS; Oh WK
    Urology; 2009 Feb; 73(2):356-61; discussion 361-2. PubMed ID: 19036418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Plasma changes caused by estrogens in the vascular risk of prostatic carcinoma over a 3-year period].
    Daponte DP; Stevens I; Robinson MR
    Actas Urol Esp; 1986; 10(6):437-40. PubMed ID: 3825644
    [No Abstract]   [Full Text] [Related]  

  • 10. [Serum testosterone and acid phosphatase levels in patients with prostatic cancer treated with Estracyt].
    Németh A; Morvay J; Vécsei B
    Orv Hetil; 1981 Apr; 122(17):1017-20. PubMed ID: 7022313
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical relevance of plasma testosterone and prolactin changes in advanced cancer of prostate treated with diethylstilbestrol or estramustine phosphate.
    Morales A; Nickel JC
    Urology; 1985 Nov; 26(5):477-81. PubMed ID: 3904134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum testosterone and sex hormone-binding globulin concentrations and the risk of prostate carcinoma: a longitudinal study.
    Heikkilä R; Aho K; Heliövaara M; Hakama M; Marniemi J; Reunanen A; Knekt P
    Cancer; 1999 Jul; 86(2):312-5. PubMed ID: 10421267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. French multicenter study on the use of estramustine phosphate versus diethylstilbestrol.
    Hauchecorne J
    Prog Clin Biol Res; 1987; 243B():229-34. PubMed ID: 3309983
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of treatment with diethylstilbestrol-polyestradiol phosphate or estramustine phosphate (estracyt) on natural killer cell activity in patients with prostatic cancer.
    Kalland T; Haukaas S
    Invest Urol; 1981 May; 18(8):437-9. PubMed ID: 7228576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Endocrine findings during hormonal treatment of metastasizing prostatic carcinoma].
    Krause W; Weidner W; Rothauge CF
    Urol Int; 1982; 37(6):400-9. PubMed ID: 6891127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of orchiectomy and various doses of stilbestrol on plasma testosterone levels in patients with carcinoma of the prostate.
    Mackler MA; Liberti JP; Smith MJ; Koontz WW; Prout GR
    Invest Urol; 1972 Mar; 9(5):423-5. PubMed ID: 5016026
    [No Abstract]   [Full Text] [Related]  

  • 17. The questionable use of hormone therapy in advanced carcinoma of the prostate.
    Murphy GP; Slack NH
    Urol Clin North Am; 1980 Oct; 7(3):631-8. PubMed ID: 6161459
    [No Abstract]   [Full Text] [Related]  

  • 18. Hypogonadism in male patients with cancer.
    Garcia JM; Li H; Mann D; Epner D; Hayes TG; Marcelli M; Cunningham GR
    Cancer; 2006 Jun; 106(12):2583-91. PubMed ID: 16688773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of diethylstilbestrol in plasma from patients with cancer of the prostate.
    Kemp HA; Read GF; Riad-Fahmy D; Pike AW; Gaskell SJ; Queen K; Harper ME; Griffiths K
    Cancer Res; 1981 Nov; 41(11 Pt 1):4693-7. PubMed ID: 7306985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of orchiectomy and various doses of stilbestrol on plasma testosterone levels in patients with carcinoma of the prostate.
    Mackler MA; Liberti JP; Smith MJ; Prout GR
    Surg Forum; 1970; 21():540-1. PubMed ID: 5535268
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.